Campylobacter fetus meningitis in a diabetic adult cured by imipenem

Eur J Clin Microbiol Infect Dis. 2004 Sep;23(9):722-4. doi: 10.1007/s10096-004-1195-4. Epub 2004 Aug 20.

Abstract

Reported here is the successful management of a severe case of Campylobacter fetus subspecies fetus meningitis, complicated by septic shock, in a patient without overt immunosuppression who was cured by imipenem. Meningitis caused by C. fetus has rarely been reported in adults, and only exceptionally in non-immunocompromised patients, and septic shock has not previously been reported as a complication of such meningitis. The best antibiotic regimen for treating this condition remains to be determined. Imipenem has displayed high in vitro activity against C. fetus but has been used rarely in clinical practice. It was administered in this case with good results.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Campylobacter Infections / complications
  • Campylobacter Infections / diagnosis
  • Campylobacter Infections / drug therapy*
  • Campylobacter fetus / drug effects
  • Campylobacter fetus / isolation & purification*
  • Critical Illness
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diagnosis
  • Emergency Service, Hospital
  • Follow-Up Studies
  • Humans
  • Imipenem / administration & dosage*
  • Infusions, Intravenous
  • Male
  • Meningitis, Bacterial / complications
  • Meningitis, Bacterial / drug therapy*
  • Meningitis, Bacterial / microbiology*
  • Risk Assessment
  • Shock, Septic / complications
  • Shock, Septic / drug therapy*
  • Shock, Septic / microbiology
  • Treatment Outcome

Substances

  • Imipenem